In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview me about the companys future R&D prospects. Given its large R&D budget, it was natural to use Pfizer … [+1341 chars]
I’m the former head of Pfizer R&D. I’m very worried about biopharma’s future - statnews.com
The New York Times once called John Lamattina, then Pfizer head of R&D, “Dr. Optimistic.” He’s not so optimistic now.
By:John L. LaMattina
Source:STAT
Published:
Related News
business
business
business
Japan Government Bond Yields, Stocks Fall After Yen’s Rebound - The Wall Street Journal
The Wall Street Journal•The Wall Street Journal
Samsung Stock Gains as Nvidia AI Chip Supply Nears - TipRanks
South Korean market leader Samsung Electronics ($SSNLF) is set to begin production of its next-generation high-bandwidth memory chips, known as HBM4, as early as next month, according to a Reuters
Tipranks.com•Shalu Saraf
Yen Extends Gains Amid Threat of Intervention: Markets Wrap - Bloomberg.com
The dollar fell against all of its major peers after a rate check Friday by the Federal Reserve Bank of New York spurred speculation the US may assist Japan in efforts to boost the yen. Gold rose above $5,000 for the first time and US stock futures dropped wi…
Bloomberg•Anand Krishnamoorthy, Ruth Carson